Thonburi Healthcare Group (THG) on Friday confirmed in a note to the Stock Exchange of Thailand that it is working with overseas dealers to procure 20 million doses of mRNA vaccine.
THG sent the clarification to the SET following a Reuters’ report on Thursday in which BioNTech and Pfizer denied they were in talks with the hospital.
“The news may cause confusion as inquiries have been made to the vaccine manufacturer,” said THG secretary Suwadee Puntpanich in the statement.
The hospital will notify the market again for a specific timeframe for vaccine importation after discussion with relevant agencies, the statement said.
Boon Vanasin, THG chairman, said on Thursday that the first lot of 5 million doses of Pfizer’s mRNA vaccine will be shipped to Thailand by the end of this month, after signing of the contract.
This caused THG’s share price to jump over 13 per cent on Thursday before slowing down and ending the day with a 6 per cent jump.
As of Friday midday, THG stock traded at 32.75 baht, up 3.97 per cent, with a transaction value of 400.8 million baht.
The Securities and Exchange Commission also said THG’s directors should stop making public statements which might influence stock price.